Preparation of amorphous solid dispersions by rotary evaporation and KinetiSol Dispersing: approaches to enhance solubility of a poorly water-soluble gum extract

References

• Karlina MV, Pozharitskaya ON, Kosman VM, Ivanova SA. Bioavailability of bowellic acids: in vitro/in vivo correlation. Pharm Chem J 2007;41:569–72
   Google Scholar
• Goel A, Ahmad FJ, Singh RM, Singh GN. Anti-inflammatory activity of nanogel formulation of 3-acetyl-11-keto-β-boswellic acid. Pharmacologyonline 2009;3:311–18
   Google Scholar
• Goel A, Ahmad FJ, Singh RM, Singh GN. 3-Acetyl-11-keto-β-boswellic acid loaded-polymeric nanomicelles for topical anti-inflammatory and anti-arthritic activity. J Pharm Pharmacol 2010;62:273–8
   PubMed Web of Science ®Google Scholar
• Gupta I, Parihar A, Malhotra P, et al. Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med 2001;67:391–5
   PubMed Web of Science ®Google Scholar
• Safahyi H, Mack T, Sabieraj J, et al. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharm Exp Ther 1992;261:1143–6
   PubMed Web of Science ®Google Scholar
• Yuan H-Q, Kong F, Wang X-L, et al. Inhibitory effect of acetyl-11-keto-β-boswellic acid on androgen receptor by interference of Sp1 binding activity in prostate cancer cells. Biochem Pharm 2008;75:2112–21
   PubMed Web of Science ®Google Scholar
• Liu JJ, Nilsson A, Oredsson S, et al. Keto- and acetyl-keto-boswellic acids inhibit proliferation and induce apoptosis in Hep G2 cells via a caspase-8 dependent pathway. Int J Mol Med 2002;10:501–5
   PubMed Web of Science ®Google Scholar
• Liu JJ, Nilsson A, Oredsson S, et al. Boswellic acids trigger apoptosis via a pathway dependent on caspase-8 activation but independent on Fas/Fas ligand interaction in colon cancer HT-29 cells. Carcinogenesis 2002;23:2087–93
   PubMed Web of Science ®Google Scholar
• Liu JJ, Huang B, Hooi SC. Acetyl-keto-β-boswellic acid inhibits cellular proliferation through a p21 dependent pathway in colon cancer cells. Br J Pharmacol 2006;148:1099–107
   PubMed Web of Science ®Google Scholar
• Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci 1971;60:1281–302
   PubMed Web of Science ®Google Scholar
• Chokshi RJ, Zia H, Sandhu HK, et al. Improving the dissolution rate of poorly water soluble drug by solid dispersion and solid solution – pros and cons. Drug Deliv 2007;14:33–45
   PubMed Web of Science ®Google Scholar
• Vippagunta SR, Wang Z, Hornung S, Krill SL. Factors affecting the formation of eutectic solid dispersions and their dissolution behavior. J Pharm Sci 2007;96:294–304
   PubMed Web of Science ®Google Scholar
• Van den Mooter G, Weuts I, De Ridder T, Blaton N. Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs. Int J Pharm 2006;316:1–6
   PubMed Web of Science ®Google Scholar
• Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50:47–60
   PubMed Web of Science ®Google Scholar
• Urbanetz NA. Stabilization of solid dispersions of nimodipine and polyethylene glycol 2000. Eur J Pharm Sci 2006;28:67–76
   PubMed Web of Science ®Google Scholar
• Taylor LS, Zografi G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res 1997;14:1691–8
   PubMed Web of Science ®Google Scholar
• Damian F, Blaton N, Naesens L, et al. Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur J Pharm Sci 2000;10:311–22
   PubMed Web of Science ®Google Scholar
• Curatolo W, Nightingale JA, Herbig SM. Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu. Pharm Res 2009;26:1419–31
   PubMed Web of Science ®Google Scholar
• DiNunzio JC, Miller DA, Yang W, et al. Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole. Mol Pharm 2008;5:968–80
   PubMed Web of Science ®Google Scholar
• Miller DA, DiNunzio JC, Yang W, et al. Targeted intestinal delivery of supersaturated itraconazole for improved oral adsorption. Pharm Res 2008;25:1450–9
   PubMed Web of Science ®Google Scholar
• Miller DA, DiNunzio JC, Yang W, et al. Enhanced in vivo absorption of itraconazole via stabilization of supersaturation following acidic-to-neutral pH transition. Drug Dev Ind Pharm 2008;34:890–902
   PubMed Web of Science ®Google Scholar
• Gao P, Rush BD, Pfund WP, et al. Devlopment of a supersaturable SEDDS formulation of paclitaxel with improved oral bioavailability. J Pharm Sci 2003;92:2386–98
   PubMed Web of Science ®Google Scholar
• Guzman HR, Tawa M, Zhang Z, et al. Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations. Pharm Sci 2007;96:2686–702
   PubMed Web of Science ®Google Scholar
• Overhoff KA, McConville JT, Yang W, et al. Effect of stabilizer on the maximum degree and extent of supersaturation and oral absorption of tacrolimus made by ultra-rapid freezing. Pharm Res 2007;25:167–75
   PubMed Web of Science ®Google Scholar
• Yamashita K, Nakate T, Okimoto K, et al. Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int J Pharm 2003;267:79–91
   PubMed Web of Science ®Google Scholar
• Jachowicz R, Nurnberg E, Hoppe R. Solid dispersions of oxazepam. Int J Pharm 1993;99:321–5
   Web of Science ®Google Scholar
• Kai T, Akiyama Y, Nomura S, Sato M. Oral absorption improvement of poorly soluble drug using solid dispersion technique. Chem Pharm Bull 1996;44:568–71
   PubMed Web of Science ®Google Scholar
• Mizuno M, Hirakura Y, Yamane I, et al. Inhibition of a solid phase reaction among excipients that accelerates drug release from a solid dispersion with aging. Int J Pharm 2005;5:37–51
   Web of Science ®Google Scholar
• Pokharkar VB, Mandpe LP, Padamwar MN, et al. Development, characterization and stabilization of amorphous form of a low Tg drug. Powder Technol 2006;67:20–5
   Web of Science ®Google Scholar
• Thybo P, Hovgaard L, Lindelov JS, et al. Scaling up the spray drying process from pilot to production scale using an atomized droplet size criterion. Pharm Res 2008;25:1610–20
   PubMed Web of Science ®Google Scholar
• Bitz C, Doelker E. Influence of the preparation method on residual solvents in biodegradable microspheres. Int J Pharm 1996;131:171–81
   Web of Science ®Google Scholar
• Ruchatz F, Kleinebudde P, Muller BW. Residual solvents in biodegradable microparticles. Influence of process parameters on the residual solvent in microparticles produced by the aerosol solvent extraction system (ASES) process. J Pharm Sci 1997;86:101–5
   PubMed Web of Science ®Google Scholar
• Ceballos A, Cirri M, Maestrelli F, et al. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets. Il Farmaco 2005;60:913–18
   PubMedGoogle Scholar
• Frizon F, de Oliveira Eloy J, Donaduzzi CM, et al. Dissolution rate enhancement of loratadine in polyvinylpyrrolidone K-30 solid dispersions by solvent methods. Powder Technol 2013;235:532–9
   Web of Science ®Google Scholar
• Andrews GP, Abudiak OA, Jones DS. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions. J Pharm Sci 2010;99:1322–35
   PubMed Web of Science ®Google Scholar
• Chokshi RJ, Sandhu HK, Iyer RM, et al. Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion process as a means to manufacture solid dispersion/solution. J Pharm Sci 2005;94:2463–74
   PubMed Web of Science ®Google Scholar
• Zheng X, Yang R, Tang X, Zheng L. Part I: Characterization of solid dispersions of nimodipine prepared by hot-melt extrusion. Drug Dev Ind Pharm 2007;33:791–802
   PubMed Web of Science ®Google Scholar
• Breitenbach J. Melt extrusion: from process to drug delivery technology. Eur J Pharm Biopharm 2002;54:107–17
   PubMed Web of Science ®Google Scholar
• Repka MA, Gerding TG, Repka SL, McGinity JW. Influence of plasticizers and drugs on the physical-mechanical properties of hydroxypropylcellulose films prepared by hot melt extrusion. Drug Dev Ind Pharm 1999;25:625–33
   PubMed Web of Science ®Google Scholar
• Repka MA, Battu SK, Upadhye SB, et al. Pharmaceutical applications of hot-melt extrusion: part II. Drug Dev Ind Pharm 2007;33:1043–57
   PubMed Web of Science ®Google Scholar
• Repka MA, Prodduturi S, Stodghill SP. Production and characterization of hot-melt extruded films containing clotrimazole. Drug Dev Ind Pharm 2003;29:757–65
   PubMed Web of Science ®Google Scholar
• Capone C, Di Landro L, Inzoli F, et al. Thermal and mechanical degradation during polymer extrusion processing. Polym Eng Sci 2007;47:1813–19
   Web of Science ®Google Scholar
• El’darov EG, Mamedov FV, Gol’dberg VM, Zaikov GE. A kinetic model of polymer degradation during extrusion. Polym Degrad Stabil 1996;51:271–9
   Web of Science ®Google Scholar
• Zborowski L, Canevarolo SV. In-line monitoring of droplets deformation and recovering and polymer degradation during extrusion. Polym Test 2012;31:254–60
   Web of Science ®Google Scholar
• DiNunzio JC, Brough C, Hughey JR, et al. Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and KinetiSol® dispersing. Eur J Pharm Biopharm 2010;74:340–51
   PubMed Web of Science ®Google Scholar
• Hughey JR, Keen JM, Brough C, et al. Thermal processing of a poorly water-soluble drug substance exhibiting a high melting point: utility of KinetiSol® Dispersing. Int J Pharm 2011;419:222–30
   PubMed Web of Science ®Google Scholar
• Hughey JR, DiNunzio JC, Bennett RC, et al. Dissolution enhancement of a drug exhibiting thermal and acidic decomposition characteristics by fusion processing: a comparative study of hot melt extrusion and KinetiSol® Dispersing. AAPS PharmSciTech 2010;11:760–74
   PubMed Web of Science ®Google Scholar
• DiNunzio JC, Hughey JR, Brough C, et al. Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol®. Drug Dev Ind Pharm 2010;36:1064–78
   PubMed Web of Science ®Google Scholar
• Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavaialability of poor water soluble drugs. Drug Discov Today 2007;12:1068–75
   PubMed Web of Science ®Google Scholar
• Liu W, He X, Li Z, et al. Development of a bionic system for the simultaneous prediction of the release/absorption characteristics of enteric-coated formulations. Pharm Res 2013;30:596–605
   PubMed Web of Science ®Google Scholar
• Stefanic M, Locatelli I, Vrecer F, et al. The influence of gastric emptying kinetics on the drug release from enteric coated pellets in fasted state: an in vitro/in vivo correlation. Eur J Pharm Biopharm 2012;82:376–82
   PubMed Web of Science ®Google Scholar
• de Waart DR, Vlaming ML, Kunne C, et al. Complex pharmacokinetic behavior of Ezetimibe depends on Abcc2, Abcc3, and Abcg2. Drug Metab Dispos 2009;37:1698–702
   PubMed Web of Science ®Google Scholar
• Hardin TC, Graybill JR, Fetchick R, et al. Pharmacokinetics of itraconazole following oral administration to normal volunteers. Antimicrob Agents Chemother 1988;32:1310–13
   PubMed Web of Science ®Google Scholar
• van Heek M, Farley C, Compton DS, et al. Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663. Br J Pharmacol 2000;129:1748–54
   PubMed Web of Science ®Google Scholar
• Kruger P, Daneshfar R, Eckert GP, et al. Metabolism of boswellic acids in vitro and in vivo. Drug Metab Dispos 2008;36:1135–42
   PubMed Web of Science ®Google Scholar
• Kruger P, Kanzer J, Hummel J, et al. Permeation of boswellia extract in the Caco-2 model and possible interactions of its constituents KBA and AKBA with OATP1B3 and MRP2. Eur J Pharm Sci 2009;36:275–84
   PubMed Web of Science ®Google Scholar